Related Experiment Video

Updated: Mar 30, 2026

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.9K

[Lymphocyte receptors that regulate the immune-response--the key to the management of antitumor immunity]

Z G Kadagidze, E G Slavina, A I Chertkova

    Voprosy Onkologii
    |November 18, 2015
    PubMed

    Insights

    Tumors evade immune surveillance by disrupting immune checkpoints, which regulate T-cell activation. Targeted drugs modulating these immune checkpoints offer a promising new direction in cancer immunotherapy.

    Area of Science:

    • Oncoimmunology
    • Molecular Biology
    • Immunology

    Background:

    • Tumors employ mechanisms to evade immune surveillance.
    • Dysregulation of co-stimulatory and co-inhibitory receptors, known as immune checkpoints, modulates T-cell activation.
    • Understanding these interactions is crucial for developing effective cancer therapies.

    Purpose of the Study:

    • To review key immune receptors involved in tumor-immune system interactions.
    • To characterize targeted drugs that modulate immune checkpoints for therapeutic purposes.
    • To highlight advancements in oncoimmunology.

    Main Methods:

    • Literature review of scientific publications.
    • Analysis of receptor functions in immune competent cells.
    • Characterization of targeted drug mechanisms.

    Main Results:

    • Identified critical co-stimulatory and co-inhibitory receptors in immune evasion.
    • Described targeted therapies impacting immune checkpoints.
    • Emphasized the role of these receptors in modulating T-cell responses against tumors.

    Conclusions:

    • Targeted drugs affecting immune checkpoints represent a significant advancement in cancer treatment.
    • Modulating immune checkpoints offers a promising therapeutic strategy for various cancers.
    • Further research into immune receptor interactions can lead to novel oncoimmunological treatments.

    More Related Videos

    Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

    Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

    Published on: March 7, 2025

    1.9K
    Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis07:45

    Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

    Published on: January 26, 2024

    3.0K

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    2.2K
    Diversity of Antigen Receptors01:28

    Diversity of Antigen Receptors

    Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
    Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
    2.1K
    Cytotoxic T Cells-mediated Immune Response01:27

    Cytotoxic T Cells-mediated Immune Response

    Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
    Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
    8.2K
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
    3.0K
    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
    8.1K
    T Cell Activation and Clonal Selection01:22

    T Cell Activation and Clonal Selection

    T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
    Naive T cells that have not yet encountered an antigen express two primary CD...
    17.3K